• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮源性一氧化氮释放剂LP - 805对体内全身血管舒张的作用。

Effect of LP-805, a releaser of endothelium-derived nitric oxide, on systemic vasodilatation in vivo.

作者信息

Inazu M, Tujitani M

机构信息

Pharmaceutical Research Laboratories, POLA R & D Laboratories, POLA Corporation, Yokohama, Japan.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):178-83. doi: 10.1007/BF00164796.

DOI:10.1007/BF00164796
PMID:8232597
Abstract

We have investigated relations between hypotensive responses to LP-805, a newly synthesized vasodilator, and the production of nitric oxide (NO), in anesthetized rats. LP-805 (0.1-0.5 mg/kg, i.v.) or acetylcholine (ACh) (0.3-3.0 micrograms/kg, i.v.) caused a dose-dependent transient decrease in diastolic blood pressure. The decrease induced by 0.3 mg/kg LP-805 (i.v.) was partially inhibited by pretreatment with NG-nitro-L-arginine (L-NNA), a specific inhibitor of endothelial NO synthase, but the responses to lower or higher doses of LP-805 (0.1 or 0.5 mg/kg, i.v.) were not affected. The dose-dependent decrease in diastolic blood pressure, caused by LP-805, was not affected by pretreatment with L- or D-arginine. The dose-dependent decrease in diastolic blood pressure caused by ACh was not affected by pretreatment with L-NNA or with L- or D-arginine. The hypotensive response to 20-min infusions of LP-805 (100 micrograms/kg per min) was significantly inhibited by pretreatment with L-NNA (10 mg/kg, i.v.). The half-recovery times (T 1/2) of LP-805 or ACh-induced depressor responses were shortened by pretreatment with L-NNA. They were prolonged by L-arginine, but not by D-arginine. This shortening, by L-NNA, of the half-recovery time after LP-805 or ACh was reversed by L-arginine, but not by D-arginine. The T 1/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin (1 mg/kg, i.v.). In the presence of L-NNA (10 mg/kg, i.v.), the T 1/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了新合成的血管舒张剂LP - 805的降压反应与麻醉大鼠体内一氧化氮(NO)生成之间的关系。LP - 805(0.1 - 0.5毫克/千克,静脉注射)或乙酰胆碱(ACh)(0.3 - 3.0微克/千克,静脉注射)可引起舒张压呈剂量依赖性的短暂下降。0.3毫克/千克LP - 805(静脉注射)引起的下降部分被内皮型一氧化氮合酶的特异性抑制剂NG - 硝基 - L - 精氨酸(L - NNA)预处理所抑制,但对较低或较高剂量的LP - 805(0.1或0.5毫克/千克,静脉注射)的反应未受影响。LP - 805引起的舒张压剂量依赖性下降不受L - 或D - 精氨酸预处理的影响。ACh引起的舒张压剂量依赖性下降不受L - NNA或L - 或D - 精氨酸预处理的影响。L - NNA(10毫克/千克,静脉注射)预处理可显著抑制对20分钟输注LP - 805(100微克/千克每分钟)的降压反应。L - NNA预处理可缩短LP - 805或ACh诱导的降压反应的半衰期(T 1/2)。L - 精氨酸可延长其半衰期,但D - 精氨酸不能。L - NNA对LP - 805或ACh后半衰期的缩短可被L - 精氨酸逆转,但不能被D - 精氨酸逆转。吲哚美辛(1毫克/千克,静脉注射)预处理不影响LP - 805诱导的降压反应的T 1/2。在存在L - NNA(10毫克/千克,静脉注射)的情况下,吲哚美辛预处理不影响LP - 805诱导的降压反应的T 1/2。(摘要截于250字)

相似文献

1
Effect of LP-805, a releaser of endothelium-derived nitric oxide, on systemic vasodilatation in vivo.内皮源性一氧化氮释放剂LP - 805对体内全身血管舒张的作用。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):178-83. doi: 10.1007/BF00164796.
2
Acetylcholine-induced systemic vasodilation resistant to NG-nitro-L-arginine in an anaesthetized rats.麻醉大鼠中对NG-硝基-L-精氨酸耐药的乙酰胆碱诱导的全身血管舒张
Clin Exp Pharmacol Physiol. 1998 Jul-Aug;25(7-8):510-6. doi: 10.1111/j.1440-1681.1998.tb02244.x.
3
Comparative effects of L-NNA and alkyl esters of L-NNA on pulmonary vasodilator responses to ACh, BK, and SP.L-NNA 及其烷基酯对肺血管对乙酰胆碱、缓激肽和 P 物质舒张反应的比较作用。
Am J Physiol. 1994 Jun;266(6 Pt 2):H2416-22. doi: 10.1152/ajpheart.1994.266.6.H2416.
4
Role of the endothelium and cyclic GMP in renal vasodilator responses to cryptolepine in rats.内皮和环磷酸鸟苷在大鼠对隐丹参酮的肾血管舒张反应中的作用。
J Cardiovasc Pharmacol. 1994 Apr;23(4):602-11. doi: 10.1097/00005344-199404000-00012.
5
Selected Contribution: Aging impairs nitric oxide and prostacyclin mediation of endothelium-dependent dilation in soleus feed arteries.精选论文:衰老损害比目鱼肌供血动脉中一氧化氮和前列环素介导的内皮依赖性舒张功能。
J Appl Physiol (1985). 2003 Nov;95(5):2164-70. doi: 10.1152/japplphysiol.01073.2002. Epub 2003 Aug 1.
6
Effects on the rabbit coronary artery of LP-805, a new type of releaser of endothelium-derived relaxing factor and a K+ channel opener.新型内皮源性舒张因子释放剂及钾通道开放剂LP-805对兔冠状动脉的影响
Circ Res. 1992 Oct;71(4):859-69. doi: 10.1161/01.res.71.4.859.
7
In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.NG-硝基精氨酸L-和D-对映体对大鼠主动脉内皮依赖性舒张的体外和离体抑制作用
J Pharmacol Exp Ther. 1993 Apr;265(1):112-9.
8
NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine.NG-硝基-L-精氨酸(N5-[亚氨基(硝基氨基)甲基]-L-鸟氨酸)通过抑制L-精氨酸的胞质一氧化氮合成来损害内皮依赖性舒张。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):143-7. doi: 10.1007/BF00195071.
9
Possible existence of novel endothelium-derived relaxing factor in the endothelium of rat mesenteric arterial bed.大鼠肠系膜动脉床内皮中可能存在新型内皮源性舒张因子。
J Cardiovasc Pharmacol. 1996 Apr;27(4):601-6. doi: 10.1097/00005344-199604000-00022.
10
Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.急性静脉内注射和短期经口给予 N(G)-硝基-L-精氨酸甲酯到大鼠体内可引起对激动剂的升压反应增强和高血压,但不抑制乙酰胆碱引起的降压反应。
Fundam Clin Pharmacol. 2011 Jun;25(3):333-42. doi: 10.1111/j.1472-8206.2010.00852.x.

引用本文的文献

1
The effects of a novel vasodilator, LP-805, on cytosolic Ca2+ concentrations and on tension in rabbit isolated femoral arteries.新型血管扩张剂LP - 805对兔离体股动脉胞浆Ca2+浓度及张力的影响。
Br J Pharmacol. 1994 Dec;113(4):1173-82. doi: 10.1111/j.1476-5381.1994.tb17121.x.

本文引用的文献

1
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.一氧化氮的释放构成了内皮源性舒张因子的生物活性。
Nature. 1987;327(6122):524-6. doi: 10.1038/327524a0.
2
Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.内皮源性舒张因子。鉴定为一氧化氮及其在血管张力和血小板功能控制中的作用。
Biochem Pharmacol. 1988 Jul 1;37(13):2495-501. doi: 10.1016/0006-2952(88)90236-5.
3
Vascular endothelial cells synthesize nitric oxide from L-arginine.
血管内皮细胞从L-精氨酸合成一氧化氮。
Nature. 1988 Jun 16;333(6174):664-6. doi: 10.1038/333664a0.
4
A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells.一种与血管内皮细胞形成一氧化氮有关的新型瓜氨酸形成酶。
Biochem Biophys Res Commun. 1989 Jan 16;158(1):348-52. doi: 10.1016/s0006-291x(89)80219-0.
5
Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.一氧化氮从L-精氨酸的生物合成。一种调节细胞功能和通讯的途径。
Biochem Pharmacol. 1989 Jun 1;38(11):1709-15. doi: 10.1016/0006-2952(89)90403-6.
6
Role of endothelium-derived nitric oxide in the regulation of blood pressure.内皮源性一氧化氮在血压调节中的作用。
Proc Natl Acad Sci U S A. 1989 May;86(9):3375-8. doi: 10.1073/pnas.86.9.3375.
7
NG-monomethyl-L-arginine-induced pressor response at developmental and established stages in spontaneously hypertensive rats.N-单甲基-L-精氨酸对自发性高血压大鼠发育阶段和成年阶段的升压反应。
J Pharmacol Exp Ther. 1991 Oct;259(1):52-7.
8
The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat.内皮源性舒张因子在大鼠肾皮质血流调节中的作用。
Br J Pharmacol. 1991 Apr;102(4):967-73. doi: 10.1111/j.1476-5381.1991.tb12285.x.
9
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.三种内皮型一氧化氮合酶抑制剂的体内外特性研究
Br J Pharmacol. 1990 Nov;101(3):746-52. doi: 10.1111/j.1476-5381.1990.tb14151.x.
10
Effects on the rabbit coronary artery of LP-805, a new type of releaser of endothelium-derived relaxing factor and a K+ channel opener.新型内皮源性舒张因子释放剂及钾通道开放剂LP-805对兔冠状动脉的影响
Circ Res. 1992 Oct;71(4):859-69. doi: 10.1161/01.res.71.4.859.